Safety of infliximab: primum non nocere. The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients
- PMID: 15475765
- DOI: 10.1097/00054725-200407000-00028
Safety of infliximab: primum non nocere. The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients
LinkOut - more resources
Full Text Sources
Medical